Literature DB >> 17295236

Epidermal hyperplasia and oral carcinoma in mice overexpressing the transcription factor ATF3 in basal epithelial cells.

Aijin Wang1, Stacey Arantes, Claudio Conti, Mark McArthur, C Marcelo Aldaz, Michael C MacLeod.   

Abstract

ATF3 is a highly conserved eukaryotic transcription factor that is ubiquitously upregulated transcriptionally during cellular responses to a variety of stresses, in particular DNA damage. However, the role of ATF3 in the DNA damage response is unclear. Transgenic mice that overexpress human ATF3 in basal epithelial cells under the control of the bovine keratin 5 (K5) promoter were constructed and characterized for epidermal alterations. Strong, nuclear expression of the exogenous ATF3 protein was seen in basal cells of the epidermis, hair follicles, and oral mucosa. Hyperplastic changes in the K5-expressing, outer root sheath (ORS) cells of the hair follicle were observed in young mice, resulting in multiple layers of ORS cells in the mature follicle and large aberrantly shaped follicles. Mild hyperplasia of the interfollicular epidermis was also noted, increasing with age. However, no epidermal tumors were identified in BK5.ATF3 mice observed for 16 mo. At 16 mo of age, most transgenic mice exhibited multi-focal areas of hyperplasia and dysplasia in the oral mucosa, with cellular atypia and underlying acute inflammatory changes. Neoplastic lesions were also seen in the oral cavity of BK5.ATF3 mice, including oral squamous cell carcinoma (60% incidence) and basal cell tumors with follicular differentiation (70% incidence), but not in non-transgenic FVB/N littermates. Heterogeneous nuclear expression (or stabilization) of p53 protein was seen in some oral dysplasias, with a patchy distribution primarily in the least differentiated layers of the lesions. This represents the first indication that ATF3 may have oncogenic properties in epithelial cells. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17295236     DOI: 10.1002/mc.20298

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  18 in total

1.  2,6-Dithiopurine, a nucleophilic scavenger, protects against mutagenesis in mouse skin treated in vivo with 2-(chloroethyl) ethyl sulfide, a mustard gas analog.

Authors:  Stephen Boulware; Tammy Fields; Elizabeth McIvor; K Leslie Powell; Erika L Abel; Karen M Vasquez; Michael C MacLeod
Journal:  Toxicol Appl Pharmacol       Date:  2012-06-23       Impact factor: 4.219

2.  Immunohistochemical detection of activating transcription factor 3, a hub of the cellular adaptive-response network.

Authors:  Tsonwin Hai; Swati Jalgaonkar; Christopher C Wolford; Xin Yin
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

Review 3.  Calcineurin signaling as a negative determinant of keratinocyte cancer stem cell potential and carcinogenesis.

Authors:  G Paolo Dotto
Journal:  Cancer Res       Date:  2011-03-15       Impact factor: 12.701

Review 4.  ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: is modulation of inflammation a unifying component?

Authors:  Tsonwin Hai; Christopher C Wolford; Yi-Seok Chang
Journal:  Gene Expr       Date:  2010

5.  ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells.

Authors:  Keita Hagiya; Jun-Ichirou Yasunaga; Yorifumi Satou; Koichi Ohshima; Masao Matsuoka
Journal:  Retrovirology       Date:  2011-03-17       Impact factor: 4.602

6.  CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas.

Authors:  Mélanie Juilland; Montserrat Gonzalez; Tabea Erdmann; Yara Banz; Zala Jevnikar; Stephan Hailfinger; Alexandar Tzankov; Michael Grau; Georg Lenz; Urban Novak; Margot Thome
Journal:  Blood       Date:  2016-01-08       Impact factor: 22.113

Review 7.  ATF3 transcription factor and its emerging roles in immunity and cancer.

Authors:  Matthew R Thompson; Dakang Xu; Bryan R G Williams
Journal:  J Mol Med (Berl)       Date:  2009-08-25       Impact factor: 4.599

8.  Opposing roles for calcineurin and ATF3 in squamous skin cancer.

Authors:  Xunwei Wu; Bach-Cuc Nguyen; Piotr Dziunycz; Sungeun Chang; Yang Brooks; Karine Lefort; Günther F L Hofbauer; G Paolo Dotto
Journal:  Nature       Date:  2010-05-20       Impact factor: 49.962

9.  Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition.

Authors:  Christina Hackl; Sven A Lang; Christian Moser; Akira Mori; Stefan Fichtner-Feigl; Claus Hellerbrand; Wolfgang Dietmeier; Hans J Schlitt; Edward K Geissler; Oliver Stoeltzing
Journal:  BMC Cancer       Date:  2010-12-03       Impact factor: 4.430

10.  Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors.

Authors:  Leqin Yan; Luis Della Coletta; K Leslie Powell; Jianjun Shen; Howard Thames; C Marcelo Aldaz; Michael C MacLeod
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.